Ferenczy Alex, Coutlée François, Franco Eduardo, Hankins Catherine
Department of Pathology, McGill University and Sir Mortimer B. Davis Jewish General Hospital, Montréal, QC.
CMAJ. 2003 Sep 2;169(5):431-4.
One of the risk factors for human papillomavirus (HPV) infection and subsequent lower genital tract neoplasias and cancers is impaired cell-mediated immunity. HIV-positive women with severe immunosuppression are 5 times more likely than HIV-negative women to have lower genital tract neoplasias. A corresponding increase in the risk of invasive vulvar and anal cancers, but not of cervical cancer, has also been observed among HIV-positive women. Treatment failure and recurrence of neoplasia occur much more frequently among HIV-positive than among HIV-negative women. In this review, we discuss recent advances in the understanding of the relation between HIV and HPV coinfection and the development of lower genital tract neoplasias and cancers in women. In addition, we present strategies for monitoring and treating noninvasive and invasive neoplasias of the lower genital tract in HIV-positive women.
细胞介导免疫受损是人类乳头瘤病毒(HPV)感染以及随后发生下生殖道肿瘤和癌症的风险因素之一。免疫严重抑制的HIV阳性女性发生下生殖道肿瘤的可能性是HIV阴性女性的5倍。在HIV阳性女性中还观察到浸润性外阴癌和肛门癌风险相应增加,但宫颈癌风险未增加。HIV阳性女性肿瘤的治疗失败和复发比HIV阴性女性更频繁。在本综述中,我们讨论了在理解HIV与HPV合并感染以及女性下生殖道肿瘤和癌症发生之间关系方面的最新进展。此外,我们还介绍了监测和治疗HIV阳性女性下生殖道非侵袭性和侵袭性肿瘤的策略。